Dimitrios Christoulas

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

Ersi Voskaridou, Dimitrios Christoulas, Antonios Bilalis et al. · Blood · 2009 · 425 citations · Full text

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post‐bortezomib monotherapy

Evangelos Terpos, Dimitrios Christoulas, Eirini Katodritou et al. · International Journal of Cancer · 2011 · 180 citations · Full text

Bone Disease, Abnormal Bone, Active Myeloma +15

Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors

Meletios Α. Dimopoulos, Maria Gavriatopoulou, Flora Zagouri et al. · Clinical Lymphoma & Myeloma · 2009 · 111 citations

Hematological Malignancy, Bortezomib-based Regimens, Urology +8

Quantitative Diffusion-weighted Imaging of the Bone Marrow: An Adjunct Tool for the Diagnosis of a Diffuse MR Imaging Pattern in Patients with Multiple Myeloma

Vassilis Koutoulidis, Sophia Fontara, Evangelos Terpos et al. · Radiology · 2016 · 97 citations

Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patients

Lia A. Moulopoulos, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · American Journal of Hematology · 2012 · 95 citations · Full text